Evidence map›Paper›PMID 41074875›Full record

ArticleProtein science : a publication of the Protein Society2025

Enriching stabilizing mutations through automated analysis of molecular dynamics simulations using BoostMut.

Kerlen T Korbeld, Maximilian J L J Fürst

Abstract read
In one paragraph

Article in Protein science : a publication of the Protein Society, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors.

Kerlen T KorbeldMolecular Enzymology, University of Groningen, Groningen, The Netherlands.
Maximilian J L J FürstMolecular Enzymology, University of Groningen, Groningen, The Netherlands.ORCID 0000-0001-7720-9214

Funding

Nederlandse Organisatie voor Wetenschappelijk Onderzoek VI.Veni.212.263
6 · The paper itself

Abstract

Thermostability is a critical goal in protein engineering for applications of biocatalysts and biomedicines. Despite striking advances in biomolecular predictive modeling, reliably identifying stabilizing mutations remains challenging. Previously, molecular dynamics (MD) simulations and visual inspection have been used as a secondary filter to improve the success rate of mutations pre-selected by thermostability algorithms. However, this approach suffers from low throughput and subjectivity. Here, we introduce Biophysical Overview of Optimal Stabilizing Mutations (BoostMut), a computational tool that standardizes and automates mutation filtering by analyzing dynamic structural features from MD. BoostMut formalizes the principles guiding manual verification, providing a consistent and reproducible stability assessment. Rigorous benchmarking across multiple datasets showed that integrating BoostMut's biophysical analysis improves the prediction rate regardless of the initial thermostability predictor. Given a modest amount of existing mutant stability data, BoostMut's performance can be further enhanced with a lightweight machine learning model. Upon experimentally validating BoostMut predictions on the enzyme limonene epoxide hydrolase, we identified stabilizing mutations previously overlooked by visual inspection and achieved a higher overall success rate. We foresee BoostMut being used for mutation filtering, as an integrated step in thermostability prediction workflows, and for labeling data to train future predictors.

Indexed as

Epoxide HydrolasesMolecular Dynamics SimulationMutationSoftwareAlgorithmsMachine LearningProtein StabilityEpoxide Hydrolasesenergy calculationsmachine learningMD simulationsprotein engineeringthermostability

Identifiers

PMID41074875
PMCPMC12514941

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.